CAS No.:109-57-9

TOXICITY DATA with REFERENCE：

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	LDLo	intravenous	110mg/kg (110mg/kg)		"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935.
mouse	LD50	intraperitoneal	1858mg/kg (1858mg/kg)		Yakugaku Zasshi. Journal of Pharmacy. Vol. 94, Pg. 1419, 1974.
mouse	LDLo	subcutaneous	700mg/kg (700mg/kg)		"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935.
rat	LD50	intraperitoneal	500mg/kg (500mg/kg)	ENDOCRINE: HYPERGLYCEMIA	Journal of Pharmacology and Experimental Therapeutics. Vol. 89, Pg. 186, 1947.
rat	LD50	oral	200mg/kg (200mg/kg)		Journal of Pharmacology and Experimental Therapeutics. Vol. 90, Pg. 260, 1947.
rat	LDLo	subcutaneous	50mg/kg (50mg/kg)		"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935.

Consensus Reports：

Reported in EPA TSCA Inventory.

SAFETY PROFILE：

Poison by ingestion, subcutaneous, and intravenous routes. Moderately toxic by intraperitoneal route. Mutation data reported. When heated to decomposition it emits very toxic NO_x and SO_x. See also ALLYL COMPOUNDS.
Hazard Codes: T
Risk Statements about Allylthiourea (CAS No.109-57-9):
R25: Toxic if swallowed.
Safety Statements:
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) 
S24/25: Avoid contact with skin and eyes.
Attention:
1. Storage: Store in a cool, dry place. Store in a tightly closed container.
2. Handling: Wash thoroughly after handling. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Do not ingest or inhale. Use only in a chemical fume hood. Do not breathe dust.

Standards and Recommendations：

 

Analytical Methods：